Moore Capital Management, LP Biomea Fusion, Inc. Transaction History
Moore Capital Management, LP
- $4.06 Billion
- Q1 2025
A detailed history of Moore Capital Management, LP transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Moore Capital Management, LP holds 77,200 shares of BMEA stock, worth $128,152. This represents 0.02% of its overall portfolio holdings.
Number of Shares
77,200Holding current value
$128,152% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BMEA
# of Institutions
109Shares Held
15.9MCall Options Held
229KPut Options Held
354K-
Cormorant Asset Management, LP Boston, MA3.57MShares$5.93 Million0.81% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$3.89 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$2.29 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY799KShares$1.33 Million0.59% of portfolio
-
Geode Capital Management, LLC Boston, MA626KShares$1.04 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $48.6M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...